Skip to main content

Evaluation and Treatment of Oncology Patients at Risk for Tumor Lysis Syndrome (TLS) — Labs — Clinical Pathway: Inpatient, ICU, Outpatient Specialty Care, ED

Tumor Lysis Syndrome Clinical Pathway — Inpatient, ICU

Labs

The table below outlines labs and frequency based on level of risk.

Labs Low Intermediate High Severe
CBC no diff Daily BID TID TID
Uric Acid Daily Q8h Q6h Q4h
BMP1, Phos2 Daily Q8h Q6h Q4h
CMP As indicated Daily Daily Daily
1. BMP not necessary if CMP is drawn
2. Consider whole blood

 

Jump back to top